Olof Eriksson Selected Research

Olof Eriksson Research Topics

Disease

10	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2016
10	Neoplasms (Cancer) 05/2016 - 05/2003
7	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2019 - 01/2011
6	Insulinoma 01/2018 - 05/2014
3	Body Weight (Weight, Body) 01/2022 - 10/2020
3	Weight Loss (Weight Reduction) 01/2022 - 12/2015
3	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2020 - 05/2013
2	Fibrosis (Cirrhosis) 01/2021 - 10/2014
2	Overweight 12/2019 - 01/2018
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2016 - 02/2016
1	Hypoxia (Hypoxemia) 06/2022
1	COVID-19 06/2022
1	Inflammation (Inflammations) 04/2022
1	Pneumonia (Pneumonitis) 04/2022
1	Lung Diseases (Lung Disease) 04/2022
1	Metabolic Diseases (Metabolic Disease) 01/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 09/2021
1	Heart Failure 01/2021
1	Infertility (Sterility) 07/2020
1	Weight Gain 12/2019
1	Fatty Liver 12/2019
1	Non-alcoholic Fatty Liver Disease 12/2019
1	Hyperlipidemias (Hyperlipidemia) 12/2019
1	Hyperphagia (Overeating) 12/2019
1	Obesity 01/2018
1	Hyperinsulinism (Hyperinsulinemia) 09/2017
1	Heart Arrest (Cardiac Arrest) 01/2016
1	Tachycardia (Tachyarrhythmias) 01/2016
1	Cardiac Arrhythmias (Arrythmia) 01/2016
1	Prostatic Neoplasms (Prostate Cancer) 06/2014
1	Hypoglycemia (Reactive Hypoglycemia) 05/2014
1	Neoplasm Metastasis (Metastasis) 05/2014
1	Glioblastoma (Glioblastoma Multiforme) 02/2014
1	Atherosclerosis 02/2014
1	Spinal Cord Injuries (Spinal Cord Injury) 02/2012
1	Carcinoma (Carcinomatosis) 11/2005

Drug/Important Bio-Agent (IBA)

7	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 05/2014
7	Exenatide (Byetta)FDA Link 01/2018 - 05/2014
6	Glucagon-Like Peptide-1 ReceptorIBA 01/2021 - 05/2014
6	Tryptophan (L-Tryptophan)FDA Link 01/2020 - 05/2013
5	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022 - 05/2014
2	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 04/2022 - 01/2021
2	Pharmaceutical PreparationsIBA 01/2022 - 11/2014
2	Peptides (Polypeptides)IBA 01/2022 - 10/2014
2	Glucagon Receptors (Glucagon Receptor)IBA 01/2021 - 10/2020
2	Metformin (Glucophage)FDA LinkGeneric 01/2021 - 09/2017
2	Insulin (Novolin)FDA Link 11/2019 - 12/2018
2	Immunoglobulin FragmentsIBA 01/2018 - 02/2016
2	CannabinoidsIBA 01/2018 - 12/2015
2	AntigensIBA 05/2016 - 06/2014
2	Biomarkers (Surrogate Marker)IBA 05/2016 - 12/2015
2	Monoclonal AntibodiesIBA 11/2014 - 06/2014
1	Leukocyte Elastase (Neutrophil Elastase)IBA 06/2022
1	somatostatin receptor 2IBA 04/2022
1	LipopolysaccharidesIBA 04/2022
1	Glucagon (Glukagon)FDA Link 01/2022
1	IncretinsIBA 01/2022
1	Carbon Tetrachloride (Tetrachloromethane)IBA 09/2021
1	SodiumIBA 01/2021
1	dapagliflozinIBA 01/2021
1	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 01/2021
1	SolventsIBA 07/2020
1	EndotoxinsIBA 07/2020
1	EnzymesIBA 12/2019
1	CeramidesIBA 12/2019
1	LipidsIBA 12/2019
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 12/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2019
1	Blood Glucose (Blood Sugar)IBA 01/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019
1	EndocannabinoidsIBA 01/2018
1	Iodine-125IBA 01/2018
1	Rosiglitazone (Avandia)FDA Link 09/2017
1	(2,4- dihydroxy- 5- isopropylphenyl)- (5- (4- methylpiperazin- 1- ylmethyl)- 1,3- dihydroisoindol- 2- yl)methanoneIBA 05/2016
1	Surface Antigens (Surface Antigen)IBA 05/2016
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 02/2016
1	CD44v6 antigenIBA 02/2016
1	RimonabantIBA 12/2015
1	Serotonin (5 Hydroxytryptamine)IBA 12/2014
1	Tyrosine Kinase InhibitorsIBA 11/2014
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 07/2014
1	IodineIBA 06/2014
1	IndiumIBA 06/2014
1	Radioisotopes (Radionuclides)IBA 06/2014
1	Antigen-Antibody Complex (Immune Complex)IBA 06/2014
1	Capromab Pendetide FDA Link 06/2014
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 02/2014
1	111In-DOTA-Z09591IBA 02/2014
1	Synthetic ResinsIBA 02/2012

Therapy/Procedure

4	Islets of Langerhans Transplantation 01/2014 - 01/2011
2	Therapeutics 04/2022 - 10/2020
2	Intravenous Administration 01/2016 - 01/2016
1	Glycemic Control 01/2022
1	Transplantation 01/2018
1	Radioimmunotherapy 05/2016
1	Stethoscopes 01/2016
1	Radiotherapy 01/2015
1	Splenectomy 05/2014
1	Laparotomy 05/2014
1	Cell- and Tissue-Based Therapy (Cell Therapy) 08/2011